29 related articles for article (PubMed ID: 8895520)
1. Impaired Antitumor Immune Response in
Kacher J; Manches O; Aspord C; Sartelet H; Chaperot L
Cancer Res Commun; 2022 Jul; 2(7):577-589. PubMed ID: 36923280
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on TAP and its vital role in antigen presentation and cross-presentation.
Mantel I; Sadiq BA; Blander JM
Mol Immunol; 2022 Feb; 142():105-119. PubMed ID: 34973498
[TBL] [Abstract][Full Text] [Related]
3. The MYC oncogene is a global regulator of the immune response.
Casey SC; Baylot V; Felsher DW
Blood; 2018 May; 131(18):2007-2015. PubMed ID: 29514782
[TBL] [Abstract][Full Text] [Related]
4. Aberrant DNA methylation in human cancers.
Li W; Chen BF
J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):798-804. PubMed ID: 24337838
[TBL] [Abstract][Full Text] [Related]
5. The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.
Mimura K; Shiraishi K; Mueller A; Izawa S; Kua LF; So J; Yong WP; Fujii H; Seliger B; Kiessling R; Kono K
J Immunol; 2013 Dec; 191(12):6261-72. PubMed ID: 24244023
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer.
Zhu MC; Xu YJ; Zou X; Yan F
Int J Colorectal Dis; 2012 Jan; 27(1):31-6. PubMed ID: 21947186
[TBL] [Abstract][Full Text] [Related]
7. Camouflage and sabotage: tumor escape from the immune system.
Poschke I; Mougiakakos D; Kiessling R
Cancer Immunol Immunother; 2011 Aug; 60(8):1161-71. PubMed ID: 21626032
[TBL] [Abstract][Full Text] [Related]
8. Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma.
Maruyama T; Mimura K; Sato E; Watanabe M; Mizukami Y; Kawaguchi Y; Ando T; Kinouchi H; Fujii H; Kono K
Br J Cancer; 2010 Aug; 103(4):552-9. PubMed ID: 20628381
[TBL] [Abstract][Full Text] [Related]
9. HLA-A and breast cancer in West Peninsular Malaysia.
Leong PP; Muhammad R; Ibrahim N; Cheong SK; Seow HF
Med Oncol; 2011 Mar; 28(1):51-6. PubMed ID: 20069393
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells.
Molenaar JJ; Ebus ME; Geerts D; Koster J; Lamers F; Valentijn LJ; Westerhout EM; Versteeg R; Caron HN
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12968-73. PubMed ID: 19525400
[TBL] [Abstract][Full Text] [Related]
11. Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
Wölfl M; Jungbluth AA; Garrido F; Cabrera T; Meyen-Southard S; Spitz R; Ernestus K; Berthold F
Cancer Immunol Immunother; 2005 Apr; 54(4):400-6. PubMed ID: 15449039
[TBL] [Abstract][Full Text] [Related]
12. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
13. In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells.
Gross N; Beck D; Favre S
Cancer Res; 1990 Dec; 50(23):7532-6. PubMed ID: 1701347
[TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.
McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; Breatnach F; Catchpoole D; Culhane AC; Jeffery I; Gallagher WM; Stallings RL
Carcinogenesis; 2004 Sep; 25(9):1599-609. PubMed ID: 15090470
[TBL] [Abstract][Full Text] [Related]
15. 1p36: every subband a suppressor?
Versteeg R; Caron H; Cheng NC; van der Drift P; Slater R; Westerveld A; Voûte PA; Delattre O; Laureys G; Van Roy N
Eur J Cancer; 1995; 31A(4):538-41. PubMed ID: 7576962
[No Abstract] [Full Text] [Related]
16. Lack of class I HLA expression in neuroblastoma is associated with high N-myc expression and hypomethylation due to loss of the MEMO-1 locus.
Cheng NC; Beitsma M; Chan A; Op den Camp I; Westerveld A; Pronk J; Versteeg R
Oncogene; 1996 Oct; 13(8):1737-44. PubMed ID: 8895520
[TBL] [Abstract][Full Text] [Related]
17. A human modifier of methylation for class I HLA genes (MEMO-1) maps to chromosomal bands 1p35-36.1.
Cheng NC; Chan AJ; Beitsma MM; Speleman F; Westerveld A; Versteeg R
Hum Mol Genet; 1996 Mar; 5(3):309-17. PubMed ID: 8852654
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
